Charlie Hospital Semarang Tbk. vs Wismilak Inti Makmur Tbk. — how do they compare? Charlie Hospital Semarang Tbk. trades at Rp270 (market cap 715.5B, 52.8K 24h volume), while Wismilak Inti Makmur Tbk. trades at Rp1,625 (market cap 3.36T, 97.9K 24h volume). The key difference: Wismilak Inti Makmur Tbk. is far larger — about 4.7× Charlie Hospital Semarang Tbk.'s market cap, and Wismilak Inti Makmur Tbk. is more actively traded (97.9K versus 52.8K). Which is the better fit depends on your goals.
| RSCH | WIIM | |
|---|---|---|
Market Cap | 715.5B | 3.36T |
Volume | 52.8K | 97.9K |
Lot | 528 | 979 |
Turnover | 14.3M | 158.4M |
Average Price | 270.9 | 1,618.02 |
Value | 14.3M | 158.4M |
Indicative Equilibrium Price | 270 | 1,625 |
Indicative Equilibrium Volume | 38.5K | 51 |
Trailing returns across standard periods
Latest headlines on both assets
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →PT Wismilak Inti Makmur Tbk (the Company) was established based on Notarial Deed No. 22 of Bagio Atmadja, S.H., dated December 14, 1994.
Read more on WIIM →